• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

既往吸烟者肺癌死亡的绝对风险模式。

Patterns of absolute risk of lung cancer mortality in former smokers.

作者信息

Halpern M T, Gillespie B W, Warner K E

机构信息

Department of Public Health Policy and Administration, School of Public Health, University of Michigan, Ann Arbor 48109-2029.

出版信息

J Natl Cancer Inst. 1993 Mar 17;85(6):457-64. doi: 10.1093/jnci/85.6.457.

DOI:10.1093/jnci/85.6.457
PMID:8445673
Abstract

BACKGROUND

It is well known that the relative risk (RR) of lung cancer mortality decreases following smoking cessation compared with the risk in persons who continue to smoke. However, changes in the absolute risk of lung cancer death following smoking cessation are not well documented. Further, few studies have examined the effect of age at smoking cessation on subsequent lung cancer death risk.

PURPOSE

The purpose of this study was to examine and compare absolute and relative lung cancer death risks in former smokers as a function of age at cessation.

METHODS

Using the American Cancer Society's Cancer Prevention Study II, a prospective cohort study with 6 years of follow-up, we modeled absolute risk of lung cancer mortality in individuals who had never smoked and in current and former smokers. The model was fit with the use of person-years logistic regression analysis.

RESULTS

Similar patterns of absolute risk of lung cancer death by age were found for all ages of smoking cessation up to the mid-60s. Lower lung cancer death risk was observed for those quitting earlier in life, and the risk for all former smokers was significantly lower than that for current smokers. For those quitting between ages 30 and 49, lung cancer death risk rose gradually with age at a rate slightly greater than that for those who had never smoked. Lung cancer death risk for former smokers quitting between ages 50 and 64 leveled off near the risk attained at the time of quitting until around age 75, when it rose sharply. At age 75, the RR for former smokers compared with current smokers was approximately 45% for those quitting in their early 60s, approximately 20% for those quitting in their early 50s, and less than 10% for those quitting in their 30s. For those who had never smoked, the RR at age 75 is less than 5%.

CONCLUSIONS

In terms of reduced risk of lung cancer mortality, smoking cessation is beneficial at any age, with much greater benefits accruing to those quitting at younger ages. Unlike previous research, which has primarily examined the effects of cessation as a function of years since quitting, our results demonstrate that age at cessation has a major impact on subsequent lung cancer risks.

IMPLICATIONS

Smokers of all ages should be encouraged to quit because cessation at any age decreases lung cancer risk relative to that of current smokers.

摘要

背景

众所周知,与继续吸烟的人相比,戒烟后肺癌死亡的相对风险(RR)会降低。然而,戒烟后肺癌死亡绝对风险的变化尚无充分记录。此外,很少有研究考察戒烟年龄对后续肺癌死亡风险的影响。

目的

本研究的目的是考察并比较不同戒烟年龄的既往吸烟者的肺癌死亡绝对风险和相对风险。

方法

利用美国癌症协会的癌症预防研究II(一项有6年随访的前瞻性队列研究),我们对从不吸烟的个体以及当前吸烟者和既往吸烟者的肺癌死亡绝对风险进行了建模。该模型采用人年逻辑回归分析进行拟合。

结果

在60多岁中期之前的所有戒烟年龄中,按年龄划分的肺癌死亡绝对风险模式相似。在生命早期戒烟者的肺癌死亡风险较低,所有既往吸烟者的风险显著低于当前吸烟者。对于30至49岁戒烟者,肺癌死亡风险随年龄逐渐上升,上升速度略高于从不吸烟者。50至64岁戒烟的既往吸烟者的肺癌死亡风险在接近戒烟时达到的风险水平保持平稳,直到75岁左右,此时风险急剧上升。在75岁时,与当前吸烟者相比,60岁出头戒烟者的RR约为45%,50岁出头戒烟者约为20%,30多岁戒烟者则不到10%。对于从不吸烟的人,75岁时的RR小于5%。

结论

就降低肺癌死亡风险而言,任何年龄戒烟都是有益的,年轻时戒烟获益更大。与以往主要考察戒烟后年限对戒烟效果影响的研究不同,我们的结果表明,戒烟年龄对后续肺癌风险有重大影响。

启示

应鼓励所有年龄段的吸烟者戒烟,因为任何年龄戒烟相对于当前吸烟者而言都能降低肺癌风险。

相似文献

1
Patterns of absolute risk of lung cancer mortality in former smokers.既往吸烟者肺癌死亡的绝对风险模式。
J Natl Cancer Inst. 1993 Mar 17;85(6):457-64. doi: 10.1093/jnci/85.6.457.
2
The change in excess risk of lung cancer attributable to smoking following smoking cessation: an examination of different analytic approaches using CPS-I data.戒烟后吸烟所致肺癌超额风险的变化:使用美国当前人口调查(CPS-I)数据对不同分析方法的考察
Cancer Causes Control. 2008 Mar;19(2):207-19. doi: 10.1007/s10552-007-9086-5. Epub 2007 Nov 9.
3
Primary prevention, smoking, and smoking cessation: implications for future trends in lung cancer prevention.一级预防、吸烟与戒烟:对肺癌预防未来趋势的影响
Cancer. 2000 Dec 1;89(11 Suppl):2506-9. doi: 10.1002/1097-0142(20001201)89:11+<2506::aid-cncr33>3.3.co;2-#.
4
Decrease in risk of lung cancer death in males after smoking cessation by age at quitting: findings from the JACC study.根据戒烟年龄分析男性戒烟后肺癌死亡风险的降低情况:JACC研究结果
Jpn J Cancer Res. 2001 Aug;92(8):821-8. doi: 10.1111/j.1349-7006.2001.tb01167.x.
5
Decrease in risk of lung cancer death in Japanese men after smoking cessation by age at quitting: pooled analysis of three large-scale cohort studies.日本男性戒烟后肺癌死亡风险随戒烟年龄的降低:三项大规模队列研究的汇总分析
Cancer Sci. 2007 Apr;98(4):584-9. doi: 10.1111/j.1349-7006.2007.00423.x.
6
Smoking cessation in relation to total mortality rates in women. A prospective cohort study.女性戒烟与总死亡率的关系。一项前瞻性队列研究。
Ann Intern Med. 1993 Nov 15;119(10):992-1000. doi: 10.7326/0003-4819-119-10-199311150-00005.
7
Smoking cessation and mortality trends among two United States populations.美国两个人口群体中的戒烟情况与死亡率趋势。
J Clin Epidemiol. 1999 Sep;52(9):813-25. doi: 10.1016/s0895-4356(99)00040-2.
8
Smoking cessation and mortality trends among 118,000 Californians, 1960-1997.1960年至1997年间118,000名加利福尼亚人的戒烟情况及死亡率趋势
Epidemiology. 1999 Sep;10(5):500-12.
9
[A prospective study on smoking, quitting and mortality in a cohort of elderly in Xi'an, China].[中国西安老年人群队列中吸烟、戒烟与死亡率的前瞻性研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2002 Jun;23(3):186-9.
10
Smoking cessation and the risk of stroke in middle-aged men.中年男性戒烟与中风风险
JAMA. 1995 Jul 12;274(2):155-60.

引用本文的文献

1
Preoperative smoking cessation interventions: a systematic review and meta-analysis.术前戒烟干预措施:一项系统评价与荟萃分析。
Perioper Med (Lond). 2025 Jan 10;14(1):5. doi: 10.1186/s13741-024-00479-4.
2
Barriers and Facilitators to Engaging in Smoking Cessation Support Among Lung Screening Participants.参与肺癌筛查者参与戒烟支持的障碍和促进因素。
Nicotine Tob Res. 2024 Jun 21;26(7):870-877. doi: 10.1093/ntr/ntad245.
3
Absolute lung cancer risk increases among individuals with >15 quit-years: Analyses to inform the update of the American Cancer Society lung cancer screening guidelines.
超过 15 年戒烟年限的个体患肺癌的绝对风险增加:为更新美国癌症协会肺癌筛查指南提供分析依据。
Cancer. 2024 Jan;130(2):201-215. doi: 10.1002/cncr.34758. Epub 2023 Nov 1.
4
Age-specific association of stage of hypertension at diagnosis with cardiovascular and all-cause mortality among elderly patients with hypertension: a cohort study.诊断时高血压分期与老年高血压患者心血管和全因死亡率的年龄相关性:一项队列研究。
BMC Cardiovasc Disord. 2023 May 23;23(1):270. doi: 10.1186/s12872-023-03250-7.
5
Co-development of an evidence-based personalised smoking cessation intervention for use in a lung cancer screening context.基于证据的个性化戒烟干预措施的共同制定,以便在肺癌筛查环境中使用。
BMC Pulm Med. 2022 Dec 15;22(1):478. doi: 10.1186/s12890-022-02263-w.
6
Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.低剂量计算机断层扫描(LDCT)筛查对肺癌相关死亡率的影响。
Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD013829. doi: 10.1002/14651858.CD013829.pub2.
7
Burden of current and past smoking across 28 European countries in 2017: A cross-sectional analysis.2017年28个欧洲国家当前及既往吸烟负担:一项横断面分析。
Tob Induc Dis. 2022 Jun 14;20:56. doi: 10.18332/tid/149477. eCollection 2022.
8
Pulmonary Inflammation and KRAS Mutation in Lung Cancer.肺癌中的肺部炎症和 KRAS 突变。
Adv Exp Med Biol. 2021;1303:71-87. doi: 10.1007/978-3-030-63046-1_5.
9
Yorkshire Enhanced Stop Smoking (YESS) study: a protocol for a randomised controlled trial to evaluate the effect of adding a personalised smoking cessation intervention to a lung cancer screening programme.约克郡强化戒烟(YESS)研究:一项随机对照试验方案,旨在评估在肺癌筛查项目中增加个性化戒烟干预措施的效果。
BMJ Open. 2020 Sep 10;10(9):e037086. doi: 10.1136/bmjopen-2020-037086.
10
High degree of polyclonality hinders somatic mutation calling in lung brush samples of COPD cases and controls.高度多克隆性妨碍 COPD 病例和对照的肺刷样体细胞突变检测。
Sci Rep. 2019 Dec 27;9(1):20158. doi: 10.1038/s41598-019-56618-1.